12/3
05:06 pm
crl
Charles River Laboratories (CRL) Shares Skyrocket, What You Need To Know [Yahoo! Finance]
Low
Report
Charles River Laboratories (CRL) Shares Skyrocket, What You Need To Know [Yahoo! Finance]
12/1
09:02 pm
crl
Charles River Laboratories International (NYSE:CRL) was given a new $185.00 price target on by analysts at Morgan Stanley.
Low
Report
Charles River Laboratories International (NYSE:CRL) was given a new $185.00 price target on by analysts at Morgan Stanley.
12/1
03:42 pm
crl
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Low
Report
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
12/1
08:00 am
crl
Charles River Laboratories to Present at Evercore Healthcare Conference
Low
Report
Charles River Laboratories to Present at Evercore Healthcare Conference
11/24
12:53 pm
crl
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
Low
Report
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
11/21
08:37 am
crl
Madison Small Cap Fund Q3 2025 Portfolio Activity [Seeking Alpha]
Low
Report
Madison Small Cap Fund Q3 2025 Portfolio Activity [Seeking Alpha]
11/17
12:08 pm
crl
Charles River Laboratories International (NYSE:CRL) was given a new $200.00 price target on by analysts at Argus.
Low
Report
Charles River Laboratories International (NYSE:CRL) was given a new $200.00 price target on by analysts at Argus.
11/17
10:23 am
crl
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.
Medium
Report
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.
11/17
09:12 am
crl
Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest [Yahoo! Finance]
Medium
Report
Drug Development Inputs & Services Stocks Q3 Teardown: Charles River Laboratories (NYSE:CRL) Vs The Rest [Yahoo! Finance]
11/17
08:00 am
crl
Charles River Laboratories to Present at Jefferies Global Healthcare Conference
Medium
Report
Charles River Laboratories to Present at Jefferies Global Healthcare Conference
11/11
11:42 am
crl
Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at Morgan Stanley from $170.00 to $185.00. They now have an "equal weight" rating on the stock.
Low
Report
Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at Morgan Stanley from $170.00 to $185.00. They now have an "equal weight" rating on the stock.
11/10
12:52 pm
crl
Charles River Laboratories International (NYSE:CRL) had its price target lowered by analysts at TD Cowen from $205.00 to $197.00. They now have a "buy" rating on the stock.
Low
Report
Charles River Laboratories International (NYSE:CRL) had its price target lowered by analysts at TD Cowen from $205.00 to $197.00. They now have a "buy" rating on the stock.
11/8
12:52 pm
crl
Charles River Labs (CRL): Assessing Valuation Following Recent Volatility and Share Price Recovery [Yahoo! Finance]
Low
Report
Charles River Labs (CRL): Assessing Valuation Following Recent Volatility and Share Price Recovery [Yahoo! Finance]
11/7
10:51 pm
crl
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
Low
Report
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
11/7
10:43 pm
crl
Charles River Labs (CRL) Is Down 6.7% After Strategic Overhaul and $1B Buyback Plan Announced [Yahoo! Finance]
Low
Report
Charles River Labs (CRL) Is Down 6.7% After Strategic Overhaul and $1B Buyback Plan Announced [Yahoo! Finance]
11/7
08:40 am
crl
DNA Manufacturing Market Size to Hit USD 20.28 Billion by 2032, Fueled by Gene Therapy and Synthetic Biology Growth – SNS Insider [Yahoo! Finance]
Low
Report
DNA Manufacturing Market Size to Hit USD 20.28 Billion by 2032, Fueled by Gene Therapy and Synthetic Biology Growth – SNS Insider [Yahoo! Finance]
11/7
06:19 am
crl
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
Low
Report
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
11/6
04:57 pm
crl
Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $160.00 to $165.00. They now have a "neutral" rating on the stock.
Low
Report
Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $160.00 to $165.00. They now have a "neutral" rating on the stock.
11/6
09:35 am
crl
Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at Barclays PLC from $195.00 to $210.00. They now have an "overweight" rating on the stock.
Low
Report
Charles River Laboratories International (NYSE:CRL) had its price target raised by analysts at Barclays PLC from $195.00 to $210.00. They now have an "overweight" rating on the stock.
11/6
08:10 am
crl
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $199.00 price target on the stock, up previously from $178.00.
Low
Report
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $199.00 price target on the stock, up previously from $178.00.
11/5
07:01 am
crl
Charles River Laboratories Provides Update on Strategic Review
Medium
Report
Charles River Laboratories Provides Update on Strategic Review
11/5
07:00 am
crl
Charles River Laboratories Announces Third-Quarter 2025 Results
Medium
Report
Charles River Laboratories Announces Third-Quarter 2025 Results
11/1
07:22 am
crl
How Recent Moves Are Rewriting the Story for Charles River Laboratories [Yahoo! Finance]
Low
Report
How Recent Moves Are Rewriting the Story for Charles River Laboratories [Yahoo! Finance]
10/27
07:17 pm
crl
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Medium
Report
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
10/27
03:00 pm
crl
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
Low
Report
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL